Neus Falgàs and Laura Mezquita join the Clínic-IDIBAPS 50/50 Programme
Both professionals will pursue a clinician-scientist career pathway, dividing their time equally between clinical care and research.
Both professionals will pursue a clinician-scientist career pathway, dividing their time equally between clinical care and research.
The Spanish Cancer Association, through its Scientific Foundation, has joined the Governing Board of the Clínic Barcelona Comprehensive Cancer Cent...
The Drug Desensitization Team within the Allergy Department has grown from performing four to five procedures per year in 2012 to nearly 500 today,...
Screening programmes have become an essential public health tool, particularly for two types of cancer: breast cancer and colorectal cancer.
This is the largest study in this field worldwide and was led by the Liver Oncology Unit (BCLC) at Clínic-IDIBAPS, within the Clínic Barcelona Comp...
Researchers from the Cancer Area at IDIBAPS and the Clínic Barcelona Comprehensive Cancer Centre have led the development of an international conse...
A study from Clínic-IDIBAPS published in Hemasphere provides a comprehensive molecular characterization of a rare tumour.
Researchers from Clínic-IDIBAPS have participated in a study published in Nature Reviews Cancer that reviews how fat-associated liver diseases, kno...
Hospital Clínic Barcelona has marked the 50th anniversary of the first allogeneic bone marrow transplant performed at the centre on June 12, 1976,...
The IDIBAPS Steering Committee approved in 2025 the creation of the new research group Translational oncology of upper gastrointestinal cancer. The...